Imaging News and Research

RSS

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

Cedars-Sinai is one of the first five medical centers in the nation and the first in Los Angeles County to achieve Comprehensive Stroke Center Certification from The Joint Commission and the American Heart Association/American Stroke Association.

11 Dec 2012

Some stroke patients may benefit from cerebral angioplasty and stent placement

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.

11 Dec 2012

MR-Ultrasound fusion biopsy can diagnose prostate cancer

Ground-breaking research by a UCLA team of physicians and engineers demonstrates that prostate cancer can be diagnosed using image-guided targeted biopsy.

11 Dec 2012

Magnetic resonance ultrasound fusion biopsy may improve prostate cancer diagnosis

Diagnosis of prostate cancer remains imperfect. Current methods of prostate biopsy are limited by over detection of slow-growing tumors and under detection of clinically relevant cancers. Investigators at the University of California-Los Angeles Department of Urology have found that a new technique of targeted biopsy in a clinic setting, using local anesthesia, may improve diagnosis and aid in selecting which patients are suitable for active surveillance and which need focal therapy (noninvasive techniques for destroying small tumors within the prostate).

11 Dec 2012

Combination of imaging and biomarker tests helps predict Alzheimer's in patients with MCI

Employing a combination of imaging and biomarker tests improves the ability of doctors to predict Alzheimer's in patients with mild cognitive impairment, according to researchers at Duke Medicine.

11 Dec 2012

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack Pharmaceuticals, Inc. today announced Phase I clinical trial results for MM-302, the company's novel agent for the treatment of advanced HER2 positive (HER2+ or ErbB2+) breast cancer.

11 Dec 2012

Combination of diagnostic tests can predict conversion from MCI to Alzheimer's

A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.

11 Dec 2012

Alpha arrestins may play a role in cell signaling that is crucial to new drug development

A newly found understanding of receptor signaling may have revealed a better way to design drugs. A study from Nationwide Children's Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a role in cell signaling that is crucial to new drug development.

11 Dec 2012

FDA expands approved use of Janssen Biotech’s Zytiga to treat men with mCRPC

The U.S. Food and Drug Administration today expanded the approved use of Zytiga (abiraterone acetate) to treat men with late-stage (metastatic) castration-resistant prostate cancer prior to receiving chemotherapy.

10 Dec 2012

Brain scans could help scientists uncover mechanisms underlying mental fatigue

We all perhaps know the feeling of mental exhaustion, but what does it mean physiologically to have mental fatigue? A new study carried out using brain scans could help scientists uncover the neurobiological mechanisms underlying mental fatigue.

10 Dec 2012

Erect radiographs reveal missed cervical spine instability

Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.

10 Dec 2012

FDA clearance for LENSAR Laser System

LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.

10 Dec 2012

Perceptive Informatics launches Customer Care office in Shanghai to serve biopharmaceutical researchers

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has opened a Customer Care office in Shanghai to service biopharmaceutical researchers in China and Taiwan who are using Perceptive's technology solutions.

From Parexel 10 Dec 2012

First Edition: December 10, 2012

Today's headlines include news about yesterday's "fiscal cliff" meeting between President Barack Obama and House Speaker John Boehner, as well as other health policy reports.

10 Dec 2012

Wellcome Trust researchers discover how brain assesses confidence in its decisions

Wellcome Trust researchers have discovered how the brain assesses confidence in its decisions. The findings explain why some people have better insight into their choices than others.

10 Dec 2012

Treadmill test can accurately predict coronary artery disease in women over 65

Although there is a widespread belief among physicians that the exercise treadmill test (ETT) is not reliable in evaluating the heart health of women, UC Davis researchers have found that the test can accurately predict coronary artery disease in women over the age of 65. They also found that two specific electrocardiogram (EKG) indicators of heart stress during an ETT further enhanced its predictive power.

8 Dec 2012

IRS releases final rules for health law's medical device tax

The 2.3 percent tax is expected to raise $29 billion over 10 years.

7 Dec 2012

Prosthetic joint infection guidelines released

The Infectious Diseases Society of American has released guidelines for the diagnosis and care of patients with a prosthetic joint infection.

7 Dec 2012

ADHD comorbidity confounds brain findings in bipolar disorder

Structural brain abnormalities found in patients with bipolar disorder may have been wrongly attributed to the condition and in fact be associated with comorbid attention–deficit hyperactivity disorder, US researchers believe.

7 Dec 2012

Ultrasound applied to fingertips can stimulate sensory pathways leading to the brain

A century after the world's first ultrasonic detection device - invented in response to the sinking of the Titanic -Virginia Tech Carilion Research Institute scientists have provided the first neurophysiological evidence for something that researchers have long suspected: ultrasound applied to the periphery, such as the fingertips, can stimulate different sensory pathways leading to the brain.

7 Dec 2012

Imaging News and Research

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

Some stroke patients may benefit from cerebral angioplasty and stent placement

MR-Ultrasound fusion biopsy can diagnose prostate cancer

Magnetic resonance ultrasound fusion biopsy may improve prostate cancer diagnosis

Combination of imaging and biomarker tests helps predict Alzheimer's in patients with MCI

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Combination of diagnostic tests can predict conversion from MCI to Alzheimer's

Alpha arrestins may play a role in cell signaling that is crucial to new drug development

FDA expands approved use of Janssen Biotech’s Zytiga to treat men with mCRPC

Brain scans could help scientists uncover mechanisms underlying mental fatigue

Erect radiographs reveal missed cervical spine instability

FDA clearance for LENSAR Laser System

Perceptive Informatics launches Customer Care office in Shanghai to serve biopharmaceutical researchers

First Edition: December 10, 2012

Wellcome Trust researchers discover how brain assesses confidence in its decisions

Treadmill test can accurately predict coronary artery disease in women over 65

IRS releases final rules for health law's medical device tax

Prosthetic joint infection guidelines released

ADHD comorbidity confounds brain findings in bipolar disorder

Ultrasound applied to fingertips can stimulate sensory pathways leading to the brain

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News